Josep Alfons Espinàs

1.7k total citations
70 papers, 1.1k citations indexed

About

Josep Alfons Espinàs is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Josep Alfons Espinàs has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in Josep Alfons Espinàs's work include Colorectal Cancer Screening and Detection (26 papers), Global Cancer Incidence and Screening (23 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Josep Alfons Espinàs is often cited by papers focused on Colorectal Cancer Screening and Detection (26 papers), Global Cancer Incidence and Screening (23 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Josep Alfons Espinàs collaborates with scholars based in Spain, United States and United Kingdom. Josep Alfons Espinàs's co-authors include Josep M. Borràs, Rebeca Font, Gemma Binefa, Joan Prades, Josep M. Argimón, Vı́ctor Moreno, Montse García, Luisa Aliste, Alı́cia Granados and Matilde Navarro and has published in prestigious journals such as PLoS ONE, Scientific Reports and Radiology.

In The Last Decade

Josep Alfons Espinàs

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep Alfons Espinàs Spain 18 588 238 187 166 149 70 1.1k
Jaume Galcerán Spain 20 803 1.4× 284 1.2× 130 0.7× 104 0.6× 167 1.1× 70 1.3k
Johan Ahlgren Sweden 23 1.0k 1.7× 253 1.1× 147 0.8× 140 0.8× 151 1.0× 68 1.7k
Eleonora Feletto Australia 17 500 0.9× 195 0.8× 77 0.4× 94 0.6× 112 0.8× 62 965
Sheetal Kircher United States 22 972 1.7× 210 0.9× 218 1.2× 434 2.6× 199 1.3× 108 1.8k
Mark Liebow United States 23 229 0.4× 146 0.6× 225 1.2× 216 1.3× 149 1.0× 44 1.5k
Michael N. Neuss United States 19 608 1.0× 160 0.7× 93 0.5× 404 2.4× 78 0.5× 51 1.6k
Kathleen Gondek United States 16 203 0.3× 249 1.0× 89 0.5× 218 1.3× 106 0.7× 43 1.0k
Beatriz Korc‐Grodzicki United States 21 371 0.6× 244 1.0× 42 0.2× 155 0.9× 268 1.8× 78 1.5k
Erika Ramsdale United States 20 430 0.7× 181 0.8× 178 1.0× 260 1.6× 78 0.5× 72 1.3k
Steven T. Fleming United States 21 561 1.0× 145 0.6× 123 0.7× 483 2.9× 85 0.6× 66 1.4k

Countries citing papers authored by Josep Alfons Espinàs

Since Specialization
Citations

This map shows the geographic impact of Josep Alfons Espinàs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Alfons Espinàs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Alfons Espinàs more than expected).

Fields of papers citing papers by Josep Alfons Espinàs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Alfons Espinàs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Alfons Espinàs. The network helps show where Josep Alfons Espinàs may publish in the future.

Co-authorship network of co-authors of Josep Alfons Espinàs

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Alfons Espinàs. A scholar is included among the top collaborators of Josep Alfons Espinàs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Alfons Espinàs. Josep Alfons Espinàs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Navarro‐Sabaté, Àurea, Rebeca Font, Josep Alfons Espinàs, et al.. (2025). Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?. Cancers. 17(2). 200–200. 1 indexed citations
2.
3.
Robles, Clàudia, Raquel Ibáñez, Esther Roura, et al.. (2024). Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia. Frontiers in Oncology. 14. 1338859–1338859.
4.
Font, Rebeca, María Buxó, Alberto Ameijide, et al.. (2022). Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred. Scientific Reports. 12(1). 8097–8097. 7 indexed citations
5.
Vanaclocha‐Espí, Mercedes, Josefa Ibáñez, Ana Molina‐Barceló, et al.. (2018). Risk factors for severe complications of colonoscopy in screening programs. Preventive Medicine. 118. 304–308. 9 indexed citations
6.
Clèries, Ramón, Alberto Ameijide, María Buxó, et al.. (2018). Long-term crude probabilities of death among breast cancer patients by age and stage: a population-based survival study in Northeastern Spain (Girona–Tarragona 1985–2004). Clinical & Translational Oncology. 20(10). 1252–1260. 11 indexed citations
7.
Román, Marta, Josep Alfons Espinàs, María Sala, et al.. (2018). Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain. The Breast Journal. 24(4). 509–518. 1 indexed citations
8.
Giordano, Livia, Luigi Bisanti, G Salamina, et al.. (2015). The EUROMED CANCER network: state-of-art of cancer screening programmes in non-EU Mediterranean countries. European Journal of Public Health. 26(1). 83–89. 20 indexed citations
9.
García, Montse, Josep M. Borràs, Gemma Binefa, et al.. (2011). Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain. European Journal of Cancer Prevention. 21(1). 42–45. 11 indexed citations
10.
García, Montse, Josep M. Borràs, Núria Milà, et al.. (2011). Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: A mixed-methods study. Preventive Medicine. 52(3-4). 265–7. 22 indexed citations
11.
Espinàs, Josep Alfons, Luisa Aliste, Esteve Fernández, et al.. (2011). Narrowing the Equity Gap: The Impact of Organized versus Opportunistic Cancer Screening in Catalonia (Spain). Journal of Medical Screening. 18(2). 87–90. 31 indexed citations
12.
Borràs, Josep Maria, et al.. (2011). Assessing the effectiveness of a guideline recommendation for pre-operative radiochemotherapy in rectal cancer. Radiotherapy and Oncology. 99(2). 142–147. 6 indexed citations
13.
Prades, Joan, Josep Alfons Espinàs, Rebeca Font, Josep M. Argimón, & Josep M. Borràs. (2011). Implementing a Cancer Fast-track Programme between primary and specialised care in Catalonia (Spain): a mixed methods study. British Journal of Cancer. 105(6). 753–759. 70 indexed citations
14.
Borràs, Josep M., et al.. (2010). Colorectal cancer OncoGuia. Clinical & Translational Oncology. 12(3). 188–210. 9 indexed citations
15.
Salas, Antonio, et al.. (2010). Colorectal Cancer OncoGuia: surgical pathology report guidelines. Clinical & Translational Oncology. 12(3). 211–213. 2 indexed citations
16.
17.
Borràs, Josep M., Josep Alfons Espinàs, & Xavier Castells. (2003). La evidencia del cribado del cáncer de mama: la historia continúa. Gaceta Sanitaria. 17(3). 249–255. 11 indexed citations
18.
Vinyoles, Ernest, et al.. (2001). CUIDA'L: un ensayo clínico que evaluará la eficacia de una intervención en cuidadores de pacientes demenciados. Atención Primaria. 27(1). 49–53. 10 indexed citations
19.
Espinàs, Josep Alfons, et al.. (1996). [Health status, use of health services and reported morbidity: application of correspondence analysis].. PubMed. 69(2). 195–206. 2 indexed citations
20.
Espinàs, Josep Alfons, et al.. (1993). [A re-evaluation of the program for diabetes mellitus type 2. A proposal for quality indices].. PubMed. 11(3). 123–6. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaume Galcerán Breakdown of academic impact, for papers by Johan Ahlgren Breakdown of academic impact, for papers by Eleonora Feletto Breakdown of academic impact, for papers by Sheetal Kircher Breakdown of academic impact, for papers by Mark Liebow Breakdown of academic impact, for papers by Michael N. Neuss Breakdown of academic impact, for papers by Kathleen Gondek Breakdown of academic impact, for papers by Beatriz Korc‐Grodzicki Breakdown of academic impact, for papers by Erika Ramsdale Breakdown of academic impact, for papers by Steven T. Fleming
Rankless by CCL
2026